| Title | Tumour Virus Research |
| Abbreviation | Tumour Virus Res. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q2); Infectious Diseases (Q2); Virology (Q2) |
| h-index | 34 |
| Overall Rank/Ranking | 5228 |
| SCImago Journal Rank (SJR) | 0.904 |
| Impact Score | 4.94 |
| Publisher | Elsevier B.V. |
| Country | Netherlands |
| ISSN | 26666790 |
| Best Quartile | Q2 |
| Coverage History | 2021-2023 |
Tumour Virus Research is a journal covering the technologies/fields/categories related to Cancer Research (Q2); Infectious Diseases (Q2); Virology (Q2). It is published by Elsevier B.V.. The overall rank of Tumour Virus Research is 5228. According to SCImago Journal Rank (SJR), this journal is ranked 0.904. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 34. The best quartile for this journal is Q2.
The ISSN of Tumour Virus Research journal is 26666790. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Tumour Virus Research is cited by a total of 208 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Tumour Virus Research is 4.94, which is computed in 2024 as per its definition. Tumour Virus Research IF is increased by a factor of 1.25 and approximate percentage change is 33.88% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Tumour Virus Research is 4.94. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.94 |
| 2022 | 3.69 |
| 2021 | 4.43 |
| 2020 | 3.82 |
| 2019 | 3.01 |
| 2018 | 2.11 |
| 2017 | 2.68 |
| 2016 | 4.29 |
| 2015 | 0.00 |
Tumour Virus Research has an h-index of 34. It means 34 articles of this journal have more than 34 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Tumour Virus Research is 26666790. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Tumour Virus Research is 5228. According to SCImago Journal Rank (SJR), this journal is ranked 0.904. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.904 |
| 2022 | 1.097 |
| 2021 | 1.146 |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 5228 |
| 2022 | 3615 |
| 2021 | 3282 |
| 2020 | 34910 |
| 2019 | 32656 |
| 2018 | 34118 |
| 2017 | 34893 |
| 2016 | 34297 |
| 2015 | 33723 |
Tumour Virus Research is published by Elsevier B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2021-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Tumour Virus Research is Tumour Virus Res.. This abbreviation ('Tumour Virus Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q2); Infectious Diseases (Q2); Virology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Tumour Virus Research latest impact IF is 4.94. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.94 (2023) and 0.00 (2015), respectively, in the last 9 years. Moreover, its average IS is 3.22 in the previous 9 years.
The Tumour Virus Research has an SJR (SCImago Journal Rank) of 0.904, according to the latest data. It is computed in the year 2024. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.146 in 2021 and the lowest being in 2020. Furthermore, the average SJR of the Tumour Virus Research over the previous 9-year period stands at 3.22.
The latest h-index of the Tumour Virus Research is 34.
The Tumour Virus Research is published by the Elsevier B.V., with its country of publication being the Netherlands.
The Tumour Virus Research is currently ranked 5228 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3282 in 2021 and its lowest position of 34910 in 2020.
The standard ISO4 abbreviation for the Tumour Virus Research is Tumour Virus Res..
Tumour Virus Research is classified as a journal that the Elsevier B.V. publishes.
The Tumour Virus Research encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Tumour Virus Research is assigned the following International Standard Serial Numbers (ISSN): 26666790.
The best quartile for the Tumour Virus Research is Q2 (2023).
The Tumour Virus Research coverage history can be summarized as follows: 2021-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Criminal Justice Review | journal | 12054 | SAGE Publications Inc. | 42 | 1.10 |
| Business Strategy Review | journal | 31512 | Wiley-Blackwell Publishing Ltd | 33 | 0.04 |
| International Journal of Research and Method in Education | journal | 5876 | Taylor and Francis Ltd. | 38 | 2.50 |
| Physics and Chemistry of the Earth | journal | 12927 | Pergamon Press Ltd. | 33 | 0.00 |
| Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | journal | 25905 | National Association of Resident Doctors of Nigeria | 25 | 0.00 |
| Brazilian Symposium of Computer Graphic and Image Processing | conference and proceedings | 16004 | 32 | 0.00 | |
| Perspectives in health information management / AHIMA, American Health Information Management Association | journal | 13267 | American Health Information Management Association | 31 | 1.32 |
| Experimental Diabetes Research | journal | 1848 | Hindawi Publishing Corporation | 57 | 0.00 |
| Georisk | journal | 2605 | Taylor and Francis Ltd. | 38 | 5.86 |
| Best Practice and Research in Clinical Anaesthesiology | journal | 3425 | Elsevier B.V. | 82 | 4.83 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.94 |
| 2022 | 3.69 |
| 2021 | 4.43 |
| 2020 | 3.82 |
| 2019 | 3.01 |
| 2018 | 2.11 |
| 2017 | 2.68 |
| 2016 | 4.29 |
| 2015 | 0.00 |
